Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Action of various antidepressant treatments reduces reactivity of noradrenergic cyclic AMP-generating system in limbic forebrain

Abstract

STUDIES on the pharmacology of the noradrenergic cyclic AMP-generating system in slices from the limbic forebrain of the rat1 and on adaptive properties of this system in conditions of persistent changes in the availability of nor-adrenaline (NA) have revealed that the system may serve as a model for the central NA receptor in this area, and that its sensitivity to NA increases or decreases when the availability of NA at the receptor site decreases or increases respectively2,3. Thus, hypersensitivity of the system has been achieved by treatment with reserpine2, a drug known to precipitate occasionally severe depressive reactions in man4, and the syndrome of which, when elicited in animals, is widely used as a model for depression5–7. Conversely, the monoamine oxidase (MAO) inhibitors, pargyline and nialamide, caused a marked reduction in the reactivity of the cyclic AMP-generating system to NA after chronic administration3. To determine whether or not antidepressant drugs which do not elevate the level of monoamines in brain share the effect of MAO inhibitors on the noradrenergic cyclic AMP-generating system, we studied the effect of the tricyclic antidepressants, desipramine and iprindole, on the reactivity of the system to NA. Desipramine blocks the uptake of NA through the neuronal membrane8,9 whereas iprindole neither blocks the neuronal uptake of NA nor alters its metabolism or turnover10,11, but is nevertheless a potent antidepressant12–14. In addition, we have tested the effect of electroconvulsive treatment (ECT), as it is generally accepted to be one of the most effective treatments for severe depression15.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Purchase on Springer Link

Instant access to full article PDF

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Blumberg, J. B., Taylor, R. E., and Sulser, F., J. Pharm. Pharmac., 27, 125–128 (1975).

    Article  CAS  Google Scholar 

  2. Blumberg, J. B., Vetulani, J., Stawarz, R. J., and Sulser, F., J. Pharmac. exp. Ther. (in the press).

  3. Vetulani, J., Stawarz, R. J., Blumberg, J. B., and Sulser, F., Fedn Proc. 34, 269 (1975).

    Google Scholar 

  4. Bunney, W. E., and Davis, J. M., Archs gen. Psychiat., 13, 483–494 (1975).

    Article  Google Scholar 

  5. Sulser, F., Watts, J. S., and Brodie, B. B., Ann. N.Y. Acad. Sci., 96, 279–288 (1962).

    Article  ADS  CAS  PubMed  Google Scholar 

  6. Vernier, V. G., Hanson, H. M., and Stone, C. A., in Psychosomatic Medicine (edit. by Nodine, T. H., and Moyer, J. H.), 683–690 (Lea and Febiger, Philadelphia, 1962).

    Google Scholar 

  7. Sulser, F., and Dingell, J. V., in Antidepressant Drugs of Non-MAO Inhibitor Type (edit. by Efron, D. H., and Kety, S. S.), 1–19 (US Department of Health, Education and Welfare, Washington, DC, 1966).

    Google Scholar 

  8. Carlsson, A., and Waldeck, B., Acta Pharmac. Toxic., 22, 293–300 (1965).

    Article  CAS  Google Scholar 

  9. Sulser, F., Owens, M. L., Strada, S. J., and Dingell, J. V., J. Pharmac. exp. Ther., 168, 272–282 (1969).

    CAS  Google Scholar 

  10. Freeman, J. J., and Sulser, F., J. Pharmac. exp. Ther., 183, 307–315 (1972).

    CAS  Google Scholar 

  11. Rosloff, B., and Davis, J. M., Psychopharmacologia, 40, 53–64 (1974).

    Article  CAS  PubMed  Google Scholar 

  12. Ayd, F. J., Dis. Nerv. Syst., 30, 818–824 (1969).

    PubMed  Google Scholar 

  13. Hicks, J. T., Ill. Med. J., 128, 622–626 (1965).

    CAS  Google Scholar 

  14. McClatchey, W. T., Moffat, T., and Irvine, G. M., J. ther. clin. Res., 1, 13–19 (1967).

    Google Scholar 

  15. Denber, H. C. B., in Psychopharmacological Treatment (edit. by Denber, H. C. B.) 121–134 (Dekker, New York, 1975).

    Google Scholar 

  16. Kakiuchi, S., and Rall, T. W., Molec. Pharmac., 4, 367–378 (1968).

    CAS  Google Scholar 

  17. Palmer, G. C., Robison, G. A., Manian, A. A., and Sulser, F., Psychopharmacologia, 23, 201–211 (1972).

    Article  CAS  PubMed  Google Scholar 

  18. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J., J. biol. Chem. 193, 265–275 (1951).

    CAS  PubMed  Google Scholar 

  19. Gilman, A. G., Proc. natn. Acad. Sci. U.S.A., 67, 305–312 (1970).

    Article  ADS  CAS  Google Scholar 

  20. Matussek, N., and Ladisich, W., Psychopharmacologia, 15, 305–309 (1969).

    Article  CAS  PubMed  Google Scholar 

  21. Papeschi, R., Randrup, A., and Lal, S., Psychopharmacologia, 35, 149–158 (1974).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

VETULANI, J., SULSER, F. Action of various antidepressant treatments reduces reactivity of noradrenergic cyclic AMP-generating system in limbic forebrain. Nature 257, 495–496 (1975). https://doi.org/10.1038/257495a0

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/257495a0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing